Intelligent bio solutions inc. announces closing of $3.0 million public offering of common stock and full exercise of the underwriter's option to purchase additional shares of common stock

New york, feb. 21, 2025 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced underwritten public offering of 1,500,000 shares of common stock at a public offering price of $2.00 per share of common stock, which included the full exercise of the underwriter's option to purchase up to 195,652 additional shares of common stock. including the option exercise, the aggregate gross proceeds from the offering were approximately $3.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the company.
INBS Ratings Summary
INBS Quant Ranking